Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split Effective December 4, 2024 Quiver Quantitative, Inc. - Sat Nov 30, 1:36AM CST

TransCode Therapeutics will implement a 1-for-33 reverse stock split effective December 4, 2024, to maintain Nasdaq listing requirements.Quiver AI SummaryTransCode Therapeutics, Inc. announced a 1-for-33...

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split GlobeNewswire - Fri Nov 29, 3:25PM CST

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics, Inc. Announces $8 Million Private Placement Agreement with Institutional Investors Quiver Quantitative, Inc. - Wed Nov 27, 4:16PM CST

TransCode Therapeutics announces an $8 million private placement of common stock and warrants for general corporate purposes.Quiver AI SummaryTransCode Therapeutics, Inc. has announced a securities purchase...

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics, Inc. Announces $8 Million Private Placement GlobeNewswire - Wed Nov 27, 6:00AM CST

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Approves 1-for-33 Reverse Stock Split to Maintain Nasdaq Listing Quiver Quantitative, Inc. - Mon Nov 25, 4:16PM CST

TransCode Therapeutics announces a 1-for-33 reverse stock split to meet Nasdaq listing requirements, effective date forthcoming.Quiver AI SummaryTransCode Therapeutics, Inc. has announced a 1-for-33 reverse...

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split GlobeNewswire - Mon Nov 25, 6:00AM CST

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Open Letter to Shareholders GlobeNewswire - Tue Nov 12, 6:00AM CST

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance GlobeNewswire - Tue Nov 5, 6:00AM CST

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data GlobeNewswire - Wed Oct 23, 6:00AM CDT

RNAZ : 3.76 (-2.34%)
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology GlobeNewswire - Thu Oct 10, 6:00AM CDT

RNAZ : 3.76 (-2.34%)

Barchart Exclusives

Holiday Trading, Key Economic Data and Other Can't Miss Items This Week Barchart - 46 minutes ago
The final trading week of 2024 arrives with shortened holiday hours and potentially thin trading volumes. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot